Research analysts have, from time to time, published material commenting on allergy therapeutics.
Any opinions, estimates or forecasts regarding the Company's performance made by such analysts are theirs alone and do not represent opinions, forecasts or predictions of the Company or its Management. You should, therefore, not place undue reliance on the content of any such analyst report or statement. The following analysts currently issue reports on us:
|Panmure Gordon||Mike Mitchell|
|Hardman & Co||Malcolm Hall & Dorothea Hill|
|FinnCap Limited||Mark Brewer|
|Stifel Financial Corp||Christian Glennie & James Mainwaring|
|Numis Securities||Paul Cuddon|
These reports cannot be obtained directly from us.